Trump announces lower drug prices in deals with 9 companies
Digest more
Several common drugs will be cheaper next year under Medicare, from weight-loss drug Ozempic to breast-cancer medication Ibrance, according to the Centers for Medicare & Medicaid Services (CMS).
Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report. The Health Resources and Services Administration, an HHS agency, reported that 340B covered entities purchased $81.
In a significant move, the Trump administration announced agreements with major drug manufacturers Eli Lilly and Novo Nordisk on November 6, 2025. These agreements aim to reduce the cost of popular GLP-1 agonist weight loss drugs and expand access for ...
New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how semaglutide and tirzepatide — which include popular drugs ...
For some GLP-1 users, the road from slim to grim is short. Surveys show that nearly 12% of Americans have turned to Ozempic, Wegovy or similar drugs to lose weight, with prescriptions more than tripling since 2020. But new research suggests many users are ...
Hosted on MSN
Top 5 most expensive drugs for consumers
President Trump put pharmaceutical CEOs on notice, demanding they lower drug prices or he promised to get involved. He penned a letter to 17 CEOs, in July, outlining what he wants from the pharma industry to cut expenses for consumers. In many cases ...
Feedback